Close X
Saturday, November 16, 2024
ADVT 
National

Officials face battle of confidence in AstraZeneca

Darpan News Desk The Canadian Press, 16 Mar, 2021 05:53 PM
  • Officials face battle of confidence in AstraZeneca

Federal officials are mounting a renewed push to instill Canadian confidence in Oxford-AstraZeneca’s COVID-19 vaccine, but observers predict they're in for a tough battle.

Members of the federal body tasked with advising the country on vaccine use took the unusual step of addressing public fears in a televised press conference Tuesday that stressed the vaccine’s safety for those over the age of 65.

The assurances come as new information leads to an update on previous advice, which initially suggested that seniors avoid the AstraZeneca vaccine because of insufficient trial data. NACI chair Dr. Caroline Quach-Thanh says there is now enough "real-world evidence" to show it is both safe and effective for seniors.

Infectious disease doctor Zain Chagla says it's an important message, but confusing for Canadians as Germany and other European countries move to limit the vaccine's use while they investigate reports of blood clots emerging after some inoculations.

The European Medicines Agency says there is no evidence of a safety concern and is "firmly convinced" that the benefits of the AstraZeneca shot outweigh the risks.

But Chagla says unfounded doubts about efficacy and safety have been deeply sown and some people will have a hard time accepting updated advice.

Reached earlier this week as he anticipated NACI's revised guidelines, he noted the AstraZeneca product has been hit especially hard in recent weeks, on multiple fronts.

“Even if all of the dust settles on all of this stuff and it's (proven) effective in 65-year-olds and it's actually 80 per cent effective and there's no clot risk, you've already introduced three strikes that are hard to wash away from people who are already hesitant to take this vaccine over Moderna and Pfizer," Chagla, a specialist at St. Joseph's Healthcare Hamilton.

Chagla said it’s up to NACI, Health Canada, and the various provincial health ministries to be transparent and clear on the evidence.

"This needs to be aggressively put out and people need to be really, really, really transparent, open and honest about this."

MORE National ARTICLES

COVAX vaccine deliveries may be smaller

COVAX vaccine deliveries may be smaller
Canada bought into it with $440 million in September, half of which secured doses for Canadians, and the other half to help buy doses for 92 nations who need help to buy vaccines.

COVAX vaccine deliveries may be smaller

429 COVID19 cases for Tuesday

429 COVID19 cases for Tuesday
There are 294 individuals currently hospitalized with COVID-19, 82 of whom are in intensive care. 

429 COVID19 cases for Tuesday

The seven vaccines Canada has pre-ordered

The seven vaccines Canada has pre-ordered
Between July 24 and Oct. 22, Canada signed deals to pre-order seven COVID-19 vaccines.

The seven vaccines Canada has pre-ordered

COVID-19 ICBC customer rebates to average $190

COVID-19 ICBC customer rebates to average $190
ICBC will begin mailing rebate cheques in mid-March 2021. This one-time rebate is separate from the Enhanced Care refunds customers will start to receive in May 2021.

COVID-19 ICBC customer rebates to average $190

Charan Gill, Founder of PICS, passes away

Charan Gill, Founder of PICS, passes away
In 1987 he founded PICS that still standing today and provides essential services to the community.

Charan Gill, Founder of PICS, passes away

Demand up, supply down in Vancouver home sales

Demand up, supply down in Vancouver home sales
The board reports 2,389 home sales in the region last month, which was a 22.8 per cent decrease from the red-hot housing market in December.

Demand up, supply down in Vancouver home sales